Evidence map›Paper›PMID 41179660›Full record

ArticleFrontiers in oncology2025

Co-occurrence patterns of esophageal and stomach cancer across 204 countries and territories: a spatial correspondence and systematic analysis.

Jiayao Xu, Jiabei Gong, Huiqiong Han, Zehua Wang, Wenjia Wang, Lei Wang, Xin Sui, Guanyu Chen, Yongxu Jia, Yanru Qin

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Jiayao Xu *Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jiabei Gong *Department of Nephropathy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Huiqiong HanDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zehua WangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wenjia WangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lei WangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xin SuiDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Guanyu ChenDepartment of Experimental Orofacial Medicine, University of Marburg, Marburg, Germany.
Yongxu JiaDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yanru QinDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophageal and gastric cancers are common malignant tumors of the digestive tract worldwide, characterized by a substantial disease burden and significant regional disparities. While these cancers share anatomical proximity, risk factors, and pathogenic mechanisms to some extent, there remains a lack of comprehensive and up-to-date global comparative studies on their co-occurrence patterns and burden trends. Methods: Using primary data from the Global Burden of Disease (GBD) 2021 study, we defined and categorized global co-occurrence patterns of esophageal and gastric cancers based on quartile methods. Descriptive analysis, correlation analysis, age-period-cohort modeling, decomposition analysis, and predictive modeling were employed to thoroughly examine the disease burden of both cancers across 204 countries and territories from 1990 to 2021. Results: The disease burden of gastric cancer consistently exceeded that of esophageal cancer in most countries and regions. Spatially, the Eastern and Northern Hemispheres, including countries such as China and Mongolia, were identified as consistent high-burden regions for both cancers. In contrast, the Western and Southern Hemispheres were predominantly characterized by single-cancer dominance or low-burden patterns. Disease burden was negatively correlated with the Socio-demographic Index (SDI), with higher burden observed in low-SDI regions. Males and older populations faced elevated disease risks. Furthermore, population growth and aging were identified as major drivers increasing the overall burden. Predictions indicate that by 2031, the age-standardized rates of both cancers will continue to decline, yet the overall burden of gastric cancer will remain significantly higher than that of esophageal cancer. Conclusions: Gastric cancer imposes a heavier disease burden than esophageal cancer across most countries and regions. These findings underscore the necessity for sustained and targeted prevention strategies, such as the promotion of healthy lifestyles, enhanced early screening, and improved healthcare accessibility in high-burden regions, to effectively reduce the global burden of esophageal and gastric cancers.

Indexed as

age-period-cohort modelBAPC modelco-occurrence patternsesophageal cancerpredictionstomach cancer

Identifiers

PMID41179660
PMCPMC12576481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.